Insight Molecular Diagnostics Inc. (IMDX) stock
IMDXNasdaqIn Vitro & In Vivo Diagnostic SubstancesFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 7/30
$1.78−0.08 (-4.30%)
Close on Nov 17, 2026Market cap $58.25MP/E –Yield –
Insight Molecular Diagnostics operating margin
Operating margin is operating income as a percentage of revenue.
Insight Molecular Diagnostics's operating margin for the twelve months ending Jun 30, 2026 was -3011.9%. For fiscal 2025 it was -1260.8%, against -3245.1% the year before. The highest annual figure on record is -1260.8% in fiscal 2025.
Annual operating margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -1260.8% | +1984.4 |
| FY2024 | Dec 31, 2024 | -3245.1% | −1572.7 |
| FY2023 | Dec 31, 2023 | -1672.4% | +206.2 |
| FY2022 | Dec 31, 2022 | -1878.6% | +565.7 |
| FY2021 | Dec 31, 2021 | -2444.3% | −0.9 |
| FY2020 | Dec 31, 2020 | -2443.3% | – |
Quarterly operating margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -4770.7% | −2870.7 |
| Q1 FY2026 | Mar 31, 2026 | -13790.6% | −13472.6 |
| Q4 FY2025 | Dec 31, 2025 | -2057.5% | +205.4 |
| Q3 FY2025 | Sep 30, 2025 | -4249.2% | +7502.9 |
| Q2 FY2025 | Jun 30, 2025 | -1900.0% | +2553.8 |
| Q1 FY2025 | Mar 31, 2025 | -318.0% | +4947.3 |
| Q4 FY2024 | Dec 31, 2024 | -2262.9% | +2889.6 |
| Q3 FY2024 | Sep 30, 2024 | -11752.2% | −10234.0 |
| Q2 FY2024 | Jun 30, 2024 | -4453.8% | −2662.5 |
| Q1 FY2024 | Mar 31, 2024 | -5265.3% | −7235.0 |
| Q4 FY2023 | Dec 31, 2023 | -5152.5% | −901.5 |
| Q3 FY2023 | Sep 30, 2023 | -1518.2% | +1028.1 |
| Q2 FY2023 | Jun 30, 2023 | -1791.4% | −1105.3 |
| Q1 FY2023 | Mar 31, 2023 | 1969.7% | +2763.6 |
| Q4 FY2022 | Dec 31, 2022 | -4251.1% | −3256.9 |
| Q3 FY2022 | Sep 30, 2022 | -2546.3% | −1163.7 |
| Q2 FY2022 | Jun 30, 2022 | -686.1% | −17.7 |
| Q1 FY2022 | Mar 31, 2022 | -793.9% | +216.7 |
| Q4 FY2021 | Dec 31, 2021 | -994.1% | +251.8 |
| Q3 FY2021 | Sep 30, 2021 | -1382.5% | −257.5 |
| Q2 FY2021 | Jun 30, 2021 | -668.4% | +5463.1 |
| Q1 FY2021 | Mar 31, 2021 | -1010.7% | +51683.1 |
| Q4 FY2020 | Dec 31, 2020 | -1245.9% | – |
| Q3 FY2020 | Sep 30, 2020 | -1125.0% | – |
| Q2 FY2020 | Jun 30, 2020 | -6131.5% | – |
| Q1 FY2020 | Mar 31, 2020 | -52693.8% | – |
See a number that looks wrong?